Literature DB >> 9029641

Association of -158 (C-->T) (XmnI) DNA polymorphism in G gamma-globin promoter with delayed switchover from fetal to adult hemoglobin synthesis.

K G Peri1, J Gagnon, C Gagnon, H Bard.   

Abstract

In this study, the effect of -158 (C-->T) (XmnI) polymorphism on the synthesis of fetal Hb and its G gamma component during the switchover from fetal to adult Hb was examined using cord blood samples from normal Caucasian term infants. The presence of -158(C-->T) mutation was determined by amplification of G gamma and A gamma-globin gene promoter fragments from the DNA isolated from cord blood samples, followed by XmnI restriction enzyme digestion. The syntheses of fetal and adult Hb in cord blood were measured by [3H]leucine incorporation in globin synthesis, separation of the globin polypeptides by HPLC, and scintillation counting of the fractions. The presence of -158(C-->T) substitution in the G gamma-globin promoter region was positively correlated with elevated synthesis of fetal Hb and its G gamma-globin component in term newborn infants and is associated with delayed switchover from fetal to adult Hb. In addition analysis of cord blood samples from 100 normal Caucasian French Canadian term infants revealed that the frequency of -158(C-->T) substitution in G gamma-promoter was 0.32.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9029641     DOI: 10.1203/00006450-199702000-00010

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  9 in total

1.  Effect of Swiss-type heterocellular HPFH from XmnI-Gγ and HBBP1 polymorphisms on HbF, HbE, MCV and MCH levels in Thai HbE carriers.

Authors:  Sasiwan Kerdpoo; Ektong Limweeraprajak; Thanusak Tatu
Journal:  Int J Hematol       Date:  2014-01-29       Impact factor: 2.490

Review 2.  Manipulation of Developmental Gamma-Globin Gene Expression: an Approach for Healing Hemoglobinopathies.

Authors:  Vigneshwaran Venkatesan; Saranya Srinivasan; Prathibha Babu; Saravanabhavan Thangavel
Journal:  Mol Cell Biol       Date:  2020-12-21       Impact factor: 4.272

3.  Influence of Xmn 1(G)γ (HBG2 c.-211 C → T) Globin Gene Polymorphism on Phenotype of Thalassemia Patients of North India.

Authors:  Ravindra Kumar; Anupriya Kaur; Sarita Agarwal
Journal:  Indian J Hematol Blood Transfus       Date:  2013-08-25       Impact factor: 0.900

4.  The Xmn1 polymorphic site 5' to the (G)gamma gene and its correlation to the (G)gamma:(A)gamma ratio, age at first blood transfusion and clinical features in beta-thalassemia patients from Western Iran.

Authors:  Hooshang Nemati; Zohreh Rahimi; Gholamreza Bahrami
Journal:  Mol Biol Rep       Date:  2009-05-15       Impact factor: 2.316

5.  The molecular basis of beta-thalassemia intermedia in southern China: genotypic heterogeneity and phenotypic diversity.

Authors:  Wanqun Chen; Xinhua Zhang; Xuan Shang; Ren Cai; Liyan Li; Tianhong Zhou; Manna Sun; Fu Xiong; Xiangmin Xu
Journal:  BMC Med Genet       Date:  2010-02-25       Impact factor: 2.103

6.  Original Research: A case-control genome-wide association study identifies genetic modifiers of fetal hemoglobin in sickle cell disease.

Authors:  Li Liu; Alexander Pertsemlidis; Liang-Hao Ding; Michael D Story; Martin H Steinberg; Paola Sebastiani; Carolyn Hoppe; Samir K Ballas; Betty S Pace
Journal:  Exp Biol Med (Maywood)       Date:  2016-03-27

7.  What influences Hb fetal production in adulthood?

Authors:  Gisele Cristine de Souza Carrocini; Paula Juliana Antoniazzo Zamaro; Claudia Regina Bonini-Domingos
Journal:  Rev Bras Hematol Hemoter       Date:  2011

8.  Association between XmnI Polymorphism and HbF Level in Sickle Cell Disease Patients from Chhattisgarh.

Authors:  Sanjana Bhagat; Pradeep Kumar Patra; Amar Singh Thakur
Journal:  Int J Biomed Sci       Date:  2012-03

9.  Efficacy and safety of oral hydroxyurea in transfusion-dependent β-thalassaemia: a protocol for randomised double-blind controlled clinical trial.

Authors:  Nirmani Yasara; Nethmi Wickramarathne; Chamila Mettananda; Aresha Manamperi; Anuja Premawardhena; Sachith Mettananda
Journal:  BMJ Open       Date:  2020-10-27       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.